Medicine · shortage history
Oxybutynin
Notified short 3 times on record since 2022 — a recurring shortage spanning 3.9 years. Every entry links to its source; grouping is by medicine name (dm+d coding will refine it).
Most recently declared short 28 Jan 2026. We record when a shortage is declared, not when stock returns — the source doesn't publish that, so this is the shortage history, not live availability. Check with your pharmacy for today's stock.
| Issued | Notice | Kind | Tier | Reference |
|---|---|---|---|---|
| 28 Jan 2026 | Medicine Supply Notification: Oxybutynin (Kentera® ) 3.9mg/24hours transdermal patches | Supply notification | Tier 2 | MSN/2026/004 |
| 24 Apr 2023 | Medicine Supply Notification: Oxybutynin 5mg modified-release tablets | Supply notification | Tier 2 | MSN/2023/048 |
| 16 Mar 2022 | Medicine Supply Notification: Oxybutynin (Kentera®) 3.9mg/24hour transdermal patches. | Supply notification | Tier 2 | MSN/2022/027 |
An update that shares a reference counts as one episode, so this list can show more rows than the count above. Grouped by the medicine named in each notice's title. Until dm+d coding lands, brand and generic names (and combination products) may sit under separate or first-ingredient entries — see methodology. Not an official NHS or DHSC service.